Esophageal Cancer Treatment Market Size and Growth, CAGR Value, Share and Revenues, Industry Trends, Business Strategies and Challenges till 2029

Research Nester released a report titled “Esophageal Cancer Treatment Market: Global Demand Analysis & Opportunity Outlook 2029” which delivers detailed overview of the global esophageal cancer treatment market in terms of market segmentation by treatment type, end-user and region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The esophageal cancer treatment market is projected to grow with a moderate CAGR during the forecast period, i.e., 2021-2029 on account of increasing research associated with esophageal cancer treatment and the rising investment in the development of advanced therapies. As per International Agency for Research on Cancer, in 2020, the assessed number of deaths from esophageal cancer globally were 544,076, which accounted for 5.5% of the total global cancer deaths.

The market is segmented by treatment type into surgery, endoscopic therapy, chemotherapy, immunotherapy, radiotherapy, targeted therapy, and others. Among these segments, the chemotherapy segment is anticipated to hold the largest share by the end of 2021 in the esophageal cancer treatment market as a result of the higher positive diagnosis rates of chemotherapy than other available treatments. It is also gaining worldwide recognition for its usage as an adjuvant therapy with radiotherapy and surgery. On the basis of end-user, the market is segmented into general medical & surgical hospitals, speciality hospitals, clinics, and others.

Download Sample of This Strategic Report

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, out of which, the esophageal cancer treatment market in the Asia Pacific is projected to grow at the highest CAGR throughout the forecast period. Currently, the market in North America holds the largest share. This can be attributed to the presence of leading healthcare providers in the region, especially in the United States, who are extensively involved in the research and development for innovative esophageal cancer treatment procedures.

Increasing Research Associated with Esophageal Cancer Treatment and Rising Investment in the Development of Advanced Therapies to Drive Market Growth

According to the American Cancer Society, in 2017, the estimated new cases and deaths from esophageal cancer in U.S. were 16,940 and 15,690 respectively.

The progress in research relating to esophageal cancer treatment has led to the discovery of various novel treatment procedures and drugs. It has been observed that increased consumption of food containing carcinogens raises the risk of having esophageal cancer. Additionally, the rising prevalence of esophageal cancer in recent years is also expected to boost the market growth in upcoming years. However, the expensive cost of cancer therapies and side effects caused by esophageal cancer treatment drugs are some of the factors that are estimated to restrain market growth in the near future.

“The Final Report will cover the impact analysis of COVID-19 on this industry.”

Download/Request Sample Copy of Strategic Report:

This report also provides the existing competitive scenario of some of the key players of the global esophageal cancer treatment market which includes company profiling of Pfizer Inc. (NYSE: PFE), Bristol Myers Squibb (NYSE: BMY), Merck & Co. (NYSE: MRK), Innovent Biologics, Inc. (HKG), Pinnacle Biologics, Inc., F. Hoffmann-La Roche AG (SWX: RO), GlaxoSmithKline plc (LON: GSK), Novartis AG (SWX: NOVN), and Genentech, Inc. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global esophageal cancer treatment market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

About Research Nester

Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.

Contact for more Info:

AJ Daniel


U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919